Reckitt has posted a strong third quarter trading update, with growth of 14 per cent.
Like-for-like revenues of the Hull-founded multinational health and hygiene operator were up 7.4 per cent. Sales so far in 2022 have now exceeded £10.6 billion for the firm behind household brands Dettol, Finish and Durex.
The company told how 70 per cent of the portfolio “less sensitive to Covid dynamics” grew in high angle digits, with health the star performer with an uplift of 10.7 per cent. It said there was “continued strong momentum led by over-the-counter brands of Mucinex, Nurofen and Strepsils, and our intimate wellness portfolio”.
